LBRN Logo

Louisiana Biomedical Research Network

NEWS

LBRN 2020 Virtual Summer Research Program

LBRN 2020 Virtual Summer Research Program

Event Date: June 8, 2020

LBRN is pleased to make available our 2020 Virtual Summer Program Opportunities for LBRN participants. This program is in place of our regular summer program, which was cancelled due to COVID-19. This program will proceed in various virtual/online formats with support from our LBRN PUI campuses and Pine BioTech Partner.

View full story

LBRN Summer Research Program 2020 Cancelled

LBRN Summer Research Program 2020 Cancelled

Event Date: 2020 Cancelled

Thank you for your interest in the LBRN Summer Research Program. We regret that owing to COVID-19 related issues LBRN Summer Research Program as advertised for 2020 is cancelled.

VIEW FULL STORY

3rd LBRN-LONI Scientific Computing Bootcamp

3rd LBRN-LONI Scientific Computing Bootcamp

Event Date: June 1-5, 2020

Scientific computing is becoming more ubiquitous for all types of research areas. Skills and knowledge that are necessary to take full advantage of the power of computing, however, are often inadequately present in both curricular and extracurricular training.

VIEW FULL STORY

PBS and LBRN Seminar Genomics of COVID-19; Analysis of Viral Genome Sequences - Follow up Lecture

PBS and LBRN Seminar Genomics of COVID-19; Analysis of Viral Genome Sequences - Follow up Lecture

Post Date: April, 22 2020

Dr. Gus Kousoulas, Principal Investigator of the Louisiana Biomedical Research Network (LBRN) that fosters biomedical research throughout Louisiana and supported by the NIH:NIGMS INBRE program, invites you to this follow up lecture given by Elia, Brodsky, CEO of Pine Biotech, Inc in collaboration with the Tauber Bioinformatics Research Center, University of Haifa, Israel and the Louisiana Biomedical Research Network (LBRN).

VIEW FULL STORY

LBRN Impromptu online seminar by Dr. Kousoulas on the molecular and cell biology of coronaviruses and especially SARS-2 CoV

LBRN Impromptu online seminar by Dr. Kousoulas on the molecular and cell biology of coronaviruses and especially SARS-2 CoV

Post Date: April, 17 2020

April 16, 2020: Dr. Gus Kousoulas, Principal Investigator of the Louisiana Biomedical Research Network (LBRN) that fosters biomedical research throughout Louisiana and supported by the NIH:NIGMS INBRE program, during his lecture on the Molecular & Cell Biology and Immunopathogenesis of coronaviruses revealed that the drug Nelfinavir mesylate (NFV; brand name Viracept), which was developed as a protease inhibitor in the treatment of the human immunodeficiency virus (HIV), caused a drastic inhibition of Spike (S)-mediated cell fusion (formation of multinucleated cells or syncytia) in cell culture experiments.

VIEW FULL STORY
News Archives